• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 64-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
XXX-0151310-1/1/2 13-Mar-2008 64APU20 3006315391 Young & Sweet Skin Care France
 
AEK-7749384-5/2/7 28-Mar-2008 64BCC24 3002106632 Global Rx Inc United States
 
M21-0737408-6/3/1 07-Mar-2008 64BCS24 3004850451 Wendt-Chemie Vertriebsges Mbh & Co. Germany
 
AEK-7960418-3/3/1 19-Mar-2008 64BDY25 3006483459 Oconnell John Canada
 
AEK-7749384-5/2/3 28-Mar-2008 64GCC13 3002106632 Global Rx Inc United States
 
XXX-0153631-8/1/11 14-Mar-2008 64LBY03 3001056209 unknown India
 
XXX-0153631-8/1/7 14-Mar-2008 64LCA19 3001056209 unknown India
 
XXX-0151421-6/1/2 13-Mar-2008 64LDJ28 3006331520 Lachifarma S.r.l Italy
 
XXX-0152493-4/1/1 07-Mar-2008 64LDJ67 3003678893 ELKO ORG.LTD Switzerland
 
XXX-0151421-6/1/1 13-Mar-2008 64LDJ67 3006331488 Celltech Pharma S.A Spain
 
112-1620762-4/2/1 13-Mar-2008 64LDK67 3006700771 Comercial Kodo Electronics Ltda Brazil
 
XXX-0151234-3/1/1 13-Mar-2008 64LDO67 3006304642 GlaxoSmithKline Saudi Arabia
 
XXX-0151234-3/1/2 13-Mar-2008 64LDO67 3006304642 GlaxoSmithKline Saudi Arabia
 
DN2-0843065-7/2/1 12-Mar-2008 64LDZ37 3005515453 Newchem Spa Italy
 
DN2-0843065-7/1/2 12-Mar-2008 64LDZ67 3005515453 Newchem Spa Italy
 
112-0116657-9/1/1 06-Mar-2008 64MCB01 3005059581 Aventis Pharma Egypt
 
802-0022478-2/1/1 13-Mar-2008 64NCA04 3002806439 Pfizer Canada Inc. Canada
 
802-0022749-6/1/1 13-Mar-2008 64NCA04 3002806439 Pfizer Canada Inc. Canada
 
802-0023042-5/1/1 13-Mar-2008 64NCA04 3002806439 Pfizer Canada Inc. Canada
 
802-0023299-1/2/1 13-Mar-2008 64NCA04 3002806439 Pfizer Canada Inc. Canada
 
802-0023174-6/1/1 13-Mar-2008 64NCA04 3002806439 Pfizer Canada Inc. Canada
 
112-1844597-4/1/3 28-Mar-2008 64RDP08 3003087150 Novartis Italy
 
AEK-7749384-5/2/2 28-Mar-2008 64UCB01 3002106632 Global Rx Inc United States
 
AEK-7749384-5/2/16 28-Mar-2008 64UCC03 3002106632 Global Rx Inc United States
 
112-2329593-4/1/1 31-Mar-2008 64UCE08 3005399923 Glaxosmithkline Italy
 
112-2329543-9/1/1 31-Mar-2008 64UCE08 3005399923 Glaxosmithkline Italy
 
112-2329642-9/1/1 31-Mar-2008 64UCE08 3005399923 Glaxosmithkline Italy
 
112-2329752-6/1/1 31-Mar-2008 64UCE08 3005399923 Glaxosmithkline Italy
 
112-2329388-9/1/1 31-Mar-2008 64UCE08 3005399923 Glaxosmithkline Italy
 
112-2329495-2/1/1 31-Mar-2008 64UIB08 1000403246 Unknown Panama
 
112-2329180-0/1/1 31-Mar-2008 64UIB08 1000403246 Unknown Panama
 
UPS-0294326-2/1/1 28-Mar-2008 64XCA11 3006714663 Roderick L Decouto Real Estate Ltd Bermuda
 
AEK-7749384-5/2/13 28-Mar-2008 64XCC07 3002106632 Global Rx Inc United States
 
112-1736382-2/1/1 12-Mar-2008 64XCJ06 3006713315 5cmv Ltd Vanuatu
 
UPS-0081419-2/1/1 04-Mar-2008 64XCS06 3006676733 Laurice Labs India
 
-
-